Search

Your search keyword '"Lung diseases -- Forecasts and trends -- Reports"' showing total 27 results

Search Constraints

Start Over You searched for: Descriptor "Lung diseases -- Forecasts and trends -- Reports" Remove constraint Descriptor: "Lung diseases -- Forecasts and trends -- Reports" Topic company growth Remove constraint Topic: company growth
27 results on '"Lung diseases -- Forecasts and trends -- Reports"'

Search Results

1. Global Respiratory Monitoring Devices Market to Register Sustainable Growth at a CAGR of ~6% by 2030 | DelveInsight

2. Interstitial Lung Disease Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | J2H Biotech, Crystec Pharma, Apie Therapeutics, BLR Bio

3. Progressive Fibrosing Interstitial Lung Disease Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight |Boehringer Ingelheim, FibroGen

4. Systemic Sclerosis-associated Interstitial Lung Disease Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | MERCK, GSK, Genentech

5. Connective Tissue Disease associated with Interstitial Lung Disease Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies - Roche, AstraZeneca

6. Pulmonary Hypertension Associated with Interstitial Lung Disease Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight

7. Global Durable Medical Equipment Strategic Business Report 2023: High Prevalence of Respiratory Diseases to Drive Growth of Oxygen Equipment and Nebulizers

8. Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight

9. Interstitial Lung Disease Market to Witness Growth by 2032, Estimates DelveInsight |Merck, Liminal Biosciences, Glenmark Pharma, Boehringer Ingelhim, Roche, United Therapeutics, Insmed, Bristol-Myers

10. Respiratory Diagnostics Global Market to Reach $9.8 Billion by 2030: Mounting Burden of Respiratory Diseases Drives Growth

11. Respiratory Diagnostics Global Market to Reach $9.8 Billion by 2030: Mounting Burden of Respiratory Diseases Drives Growth

12. Homecare oxygen concentrators market size to grow by USD 1,476.28 million from 2022 to 2027: Growth driven by increasing prevalence of respiratory diseases - Technavio

13. Progressive Fibrosing Interstitial Lung Disease Market to Observe Impressive Growth by (2022-2032), Evaluates DelveInsight | Key Companies - Boehringer Ingelheim, FibroGen, Bristol-Myers Squibb

14. Growing Prevalence of Chronic Respiratory Diseases to Help Growth of Global Pulmonary Drug Delivery Devices Market to Reach Valuation Worth US$47,452.8 Mn by 2027 End

15. Interstitial Lung Disease Pipeline Assessment, 2022: In-depth Analysis into the Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, Growth Prospects, and Key Companies Involved

16. Global Pulse Oximeter Market Research Report 2022: Increase in the Prevalence of Respiratory Diseases and Other Target Diseases Driving Growth

17. Portable Oxygen Concentrators Market Size to Grow by USD 1.51 Bn| Increasing prevalence of respiratory diseases to boost market growth| Technavio

18. Portable Oxygen Concentrators Market Size to Grow by USD 1.51 Bn| Increasing prevalence of respiratory diseases to boost market growth| Technavio

19. Interstitial Lung Disease Market to Register Incremental Growth During the Forecast Period 2030 | Key Companies - Roche, aTyr Pharma. Galapagos, OncoArendi, and Others

20. Outlook on the Pulmonary Drugs Global Market to 2026 - Rising Prevalence of Pulmonary Diseases is Driving Growth

21. Outlook on the Pulmonary Drugs Global Market to 2026 - Rising Prevalence of Pulmonary Diseases is Driving Growth

22. Respiratory Monitoring Devices Market - Roadmap for Recovery from COVID-19 | Increasing Prevalence of Chronic Respiratory Diseases to boost the Market Growth | Technavio

23. Respiratory Monitoring Devices Market - Roadmap for Recovery from COVID-19 | Increasing Prevalence of Chronic Respiratory Diseases to boost the Market Growth | Technavio

24. Prevailing Respiratory Disease is propelling Growth in the Global Ventilator Market

25. Growing Prevalence of Chronic Respiratory Diseases to Help Growth of Global Pulmonary Drug Delivery Devices Market to Reach Valuation Worth US$47,452.8 Mn by 2027 End

26. Surge in Respiratory Diseases is Pushing the Growth of Global Nasal Spray Device Market

27. Pulmonary Function Testing Systems Market Growth Prospects, Latest Trends and New Technologies Professional Research Report 2018 Stated by Market Research Future

Catalog

Books, media, physical & digital resources